Hair Follicle Tumors: Benign vs. Malignant Types

Hair follicle tumors are growths that originate from or mimic the structures of a normal hair follicle. Most are benign, but the category spans a wide range, from harmless lumps a child might develop on the scalp to rare aggressive cancers that can metastasize. What makes them unusual among skin growths is their diversity: because the hair follicle itself is one of the most complex mini-organs in the body, tumors arising from it can resemble any of its many components, which makes them fascinating to researchers and genuinely tricky for pathologists to classify.

What Makes a Tumor a “Hair Follicle Tumor”

A hair follicle is not just a hole that sprouts a hair. It contains distinct zones, each with its own cell type and function: the bulge region houses stem cells, the matrix at the base produces the hair shaft, the outer root sheath wraps the follicle, the inner root sheath molds the hair’s shape, and the dermal papilla at the bottom sends growth signals. Tumors in this family recapitulate one or more of those structures. Some mimic the hair matrix and produce ghost cells that look like shadow outlines of dead hair cells. Others resemble the follicle’s outer sheath. Still others look like the earliest embryonic hair germ, the cluster of cells that forms before a follicle even exists. This is a large and varied group of growths that share a common origin and display features resembling one or several portions of the normal follicle, or even replay parts of its embryonic development.

1PubMed Central. Benign follicular tumors

The complexity of the follicle also explains why these tumors create headaches in the pathology lab. Different follicular structures overlap in appearance, and the follicle itself cycles through growth, regression, and rest phases, further expanding the range of what “normal follicle tissue” can look like under a microscope. Practicing pathologists sometimes find the diagnostic distinctions genuinely difficult, even with experience.

The Most Common Benign Types

Benign hair follicle tumors vastly outnumber malignant ones. A few show up regularly in dermatology clinics.

Pilomatricoma

Sometimes called a calcifying epithelioma, pilomatricoma is one of the most common hair follicle tumors and is especially frequent in children and young adults. It typically appears as a firm, skin-colored or slightly bluish lump, often on the head, neck, or upper arms. It derives from the hair matrix, the part of the follicle responsible for building the hair shaft. Under a microscope, the tumor contains characteristic “shadow” or “ghost” cells: outlines of cells whose nuclei have dissolved, leaving behind pale empty shapes. Pilomatricomas are entirely benign, and simple surgical removal is curative. The growth is driven by overactivation of a signaling protein called beta-catenin, the same molecular pathway involved in normal hair development. Studies have found that roughly 80% of pilomatricomas show abnormal accumulation of beta-catenin in cell nuclei, and about 60% carry mutations in the gene that codes for it.

2PubMed. beta-Catenin mutation and its nuclear localization are confirmed to be frequent causes of Wnt signaling pathway activation in pilomatricomas

When examined with a dermatoscope, pilomatricomas have a recognizable pattern: irregular white structures appear in most cases, along with a mix of vessel types and reddish areas.

3Dermatology. Dermoscopic Findings of Pilomatricomas

That combination of features helps clinicians suspect the diagnosis before biopsy, though the final word always comes from looking at the tissue under a microscope.

Trichoepithelioma and Trichoblastoma

Trichoepithelioma and trichoblastoma are both benign tumors derived from hair germ cells, the embryonic precursors of the follicle. They most often develop on the face and scalp in adults.

4PubMed. Trichoblastoma and Trichoepithelioma

A trichoepithelioma tends to be small, sitting in the upper dermis, and is made up of tiny lobules of cells that look nearly identical to basal cell carcinoma (BCC) under the microscope. The key distinguishing feature is that trichoepitheliomas are surrounded by prominent specialized connective tissue that mimics the papillary bodies found in a developing follicle. Trichoblastoma, on the other hand, can grow larger, sometimes reaching three centimeters or more, and occupies the full thickness of the dermis. It also has both an epithelial and a connective tissue component, reproducing the interaction between follicle and surrounding tissue seen during hair development. Both follow a benign course.

5Diagnostic Histopathology. An overview of hair follicle tumours

Trichilemmoma

Trichilemmoma derives from the outer root sheath of the hair follicle. It usually appears as a small, wart-like papule on the face, particularly around the nose and mouth. A single trichilemmoma is almost always harmless and may not even need treatment. However, when multiple trichilemmomas appear together, they can signal a genetic condition called Cowden syndrome, which is discussed further below.

Why These Tumors Look So Much Like Basal Cell Carcinoma

The resemblance between benign hair follicle tumors and BCC is not a coincidence. Research has shown that many basal cell carcinomas actually originate from hair follicle stem cells themselves. In mouse studies, when the signaling molecule Smoothened (part of the Hedgehog pathway) is activated in stem cells of the follicular bulge, basal cell carcinoma-like tumors can develop, particularly after wounding mobilizes those stem cells out of the follicle and into the surrounding skin.

6PubMed Central. Wounding mobilizes hair follicle stem cells to form tumors

Separate cell-fate tracking experiments in mice with a mutation in the Patched1 gene found that radiation-induced BCCs arose almost exclusively from keratin-15-expressing stem cells of the follicular bulge.

7PubMed Central. Basal cell carcinomas arise from hair follicle stem cells in Ptch1(+/-) mice

So BCC, the most common cancer in humans, is itself arguably a hair follicle-derived tumor. That shared ancestry means benign follicular growths and BCC can look strikingly similar under the microscope. Distinguishing a trichoepithelioma from a BCC is important because the treatments are very different: BCC requires complete removal and may need aggressive follow-up, while a trichoepithelioma can sometimes just be watched. Pathologists use a combination of architectural clues, like the pattern of surrounding stroma, and immunohistochemical stains to make the distinction. A protein called PHLDA1, which is strongly expressed in hair follicle cells, stains positively in trichoepithelioma but not in BCC, making it one of the more useful markers.

8Dermatopathology. Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update

Even with these tools, the distinction remains challenging, especially in small biopsy specimens where the pathologist has limited tissue to examine.

9PubMed. Diagnostic accuracy of immunohistochemical markers in differentiation between basal cell carcinoma and trichoepithelioma in small biopsy specimens

The Molecular Pathways Behind Follicular Tumors

Two major signaling pathways keep coming up in follicular tumor biology: the Wnt/beta-catenin pathway and the Hedgehog pathway. Both are critical for normal hair follicle development, and both can drive tumor formation when they go haywire.

The Wnt pathway centers on a protein called beta-catenin. In normal hair biology, beta-catenin helps initiate hair follicle formation during embryonic development and plays a role during each growth cycle of the follicle throughout life. When researchers engineered mice to express a stabilized version of beta-catenin in skin cells, the animals developed what looked like new hair follicles sprouting from scratch, something that normally only happens before birth. The new follicles even formed their own sebaceous glands and dermal papillae. But the growth did not stop: it kept going and produced tumors resembling pilomatricoma and trichofolliculoma, both recognized human follicular tumors.

10Cell. De Novo Hair Follicle Morphogenesis and Hair Tumors in Mice Expressing a Truncated β-Catenin in Skin

In human pilomatricomas, the same pathway is consistently active: all analyzed tumors in one study showed intense nuclear beta-catenin staining, and mutations in the beta-catenin gene were confirmed in every case where adequate DNA was recovered.

11PubMed. beta-Catenin gene mutation in human hair follicle-related tumors

The Hedgehog pathway, meanwhile, is central to BCC and related tumors. The signal molecule Sonic Hedgehog helps regulate follicle cycling, and when its target genes are switched on at the wrong time, epithelial tumors develop. Interestingly, the timing of the hair cycle matters: in mice with a Patched1 mutation, tumor precursors formed only during the active growth phase (anagen), not during the resting phases. This suggests the follicle is only vulnerable to these tumors at certain points in its cycle.

12PubMed. Hair cycle regulation of Hedgehog signal reception

Follicular stem cells are also implicated in squamous cell carcinoma of the skin. Research has identified that stem cells in the hair follicle bulge that express a marker called Lgr5 can serve as the origin for cutaneous squamous cell carcinoma when growth-promoting signals are activated and a tumor-suppressing pathway is lost simultaneously.

13Cancer Research. Abstract 1506: Frequent loss of function mutations in TGFβR1 and TGFβR2 identify hair follicle bulge stem cells as the cell of origin for cutaneous squamous cell carcinoma

When Follicular Tumors Run in Families

Most hair follicle tumors appear sporadically, with no family connection. But a handful of genetic syndromes cause them to develop in clusters, and recognizing these patterns matters because the syndromes carry broader health implications.

Brooke-Spiegler Syndrome

Brooke-Spiegler syndrome is an inherited condition in which people develop multiple skin appendage tumors, most commonly spiradenomas, cylindromas, and trichoepitheliomas. It follows an autosomal dominant inheritance pattern, meaning a single copy of the mutated gene can cause the disease. The responsible gene is CYLD, a tumor suppressor located on chromosome 16.

14PubMed Central. Brooke-Spiegler Syndrome and Phenotypic Variants: An Update

A related condition called multiple familial trichoepithelioma causes numerous trichoepitheliomas without the other tumor types; it is considered a milder variant of the same genetic problem. CYLD mutations are found in about 80-85% of patients with the full Brooke-Spiegler phenotype and in about 40-50% of those with the trichoepithelioma-only variant.

15PubMed Central. Brooke-Spiegler Syndrome and Phenotypic Variants: An Update

Different families carry different CYLD mutations, and so far no clear pattern has emerged linking specific mutations to specific clinical presentations. The same mutation can produce different tumor combinations in different people.

16PubMed. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation

Cowden Syndrome and Trichilemmomas

Cowden syndrome is caused by mutations in the PTEN gene and carries an increased risk of breast, thyroid, and endometrial cancers. Multiple facial trichilemmomas are one of its hallmark skin findings. Researchers have found that trichilemmomas associated with Cowden syndrome almost always show complete loss of PTEN protein: about 83% of Cowden-associated trichilemmomas had total PTEN loss, compared with only about 3% of sporadic trichilemmomas that occurred by chance in people without the syndrome.

17PubMed. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors

This means that testing a trichilemmoma biopsy for PTEN loss can be a useful clue pointing toward Cowden syndrome, which might otherwise go undiagnosed until a more serious internal cancer is found. A single trichilemmoma on someone’s nose is nothing to worry about; multiple ones appearing together should prompt a conversation with a doctor about possible genetic screening.

Malignant Follicular Tumors

While most hair follicle tumors are benign, a small number are genuinely dangerous. Pilomatrix carcinoma is the malignant counterpart of pilomatricoma. It is rare but aggressive, with a notable tendency to recur after standard surgical removal. In a systematic review of treated cases, surgical excision carried a recurrence rate of about 35%, while Mohs micrographic surgery, a technique that examines tissue margins layer by layer during the procedure, had zero recurrences across all 17 reported cases.

18PubMed. Surgical treatment of pilomatrix carcinoma: a systematic review

Trichoblastic carcinoma is another rare malignant follicular tumor, and it is especially problematic because it closely mimics BCC under the microscope, leading to frequent misdiagnosis. It typically presents as a nodular, sometimes ulcerated lesion on the face or scalp. Unlike ordinary BCC, trichoblastic carcinoma has a high potential for metastasis, making accurate diagnosis critical.

19PubMed. Trichoblastic carcinoma: a systematic review of an aggressive follicular neoplasm with an emphasis on Mohs micrographic surgery in management

Treatment Approaches

For most solitary benign follicular tumors, treatment is straightforward: either leave them alone if they are not bothersome, or surgically remove them. Simple excision is curative for a pilomatricoma, a lone trichoepithelioma, or a trichilemmoma, and recurrence after complete removal is rare. When tumors are located on the head, neck, or face, or when they are large, recurrent, or show aggressive behavior, Mohs micrographic surgery is often preferred because it allows the surgeon to check margins in real time and spare as much healthy tissue as possible.

20Dermatologic Surgery. Utilization of Mohs Micrographic Surgery for Benign Adnexal Tumors of the Skin: A Systematic Review

The challenge is different for patients with inherited syndromes who develop dozens or even hundreds of tumors over a lifetime. Repeatedly excising each new growth is impractical and cosmetically burdensome. For multiple familial trichoepitheliomas, researchers have explored topical sirolimus (also known as rapamycin), a drug that suppresses certain cell-growth signals. In a reported case series, two siblings with multiple facial trichoepitheliomas were treated with topical sirolimus cream, one in combination with laser ablation and the other with the cream alone. Both had a reduction in new lesion growth and no side effects.

21PubMed. Use of topical sirolimus in the management of multiple familial trichoepitheliomas

This is still early-stage evidence, but it represents a shift toward non-surgical management for patients who face a lifelong burden of recurring tumors.

The Emotional Weight of Visible Facial Tumors

When multiple trichoepitheliomas cluster on the face, the impact goes well beyond the skin. The psychological burden is often the main reason patients seek treatment in the first place. In a study of patients who underwent diode laser treatment for multiple trichoepitheliomas, those who completed treatment reported improved quality of life, better interpersonal relationships, and greater willingness to engage in social activities.

22Journal of the Egyptian Women’s Dermatologic Society. A novel technique for the treatment of multiple trichoepitheliomas using a high-intensity diode laser

That finding may seem obvious, but it underscores a point that clinical descriptions of these tumors sometimes miss: a condition classified as “benign” can still profoundly affect someone’s daily life. Patients with Brooke-Spiegler syndrome or multiple familial trichoepithelioma can spend decades managing visible tumors that grow back after removal, and the decision to treat or not treat involves emotional calculus as much as medical judgment.

Follicular Tumors in Animals

Hair follicle tumors are not unique to humans. They occur in many species and are especially common in dogs. Veterinary dermatopathologists use a classification system that parallels the human one, with tumors named for the follicular structures they resemble.

23PubMed Central. Histologic features of hair follicle neoplasms and cysts in dogs and cats: a diagnostic guide

Trichoblastomas, pilomatricomas, and infundibular keratinizing acanthomas are all recognized in veterinary medicine. The biology is broadly comparable: the same follicular structures give rise to the same tumor types. For pet owners, the practical takeaway is that a firm lump on a dog’s skin that does not go away may warrant a biopsy, but the odds are strongly in favor of it being benign. Malignant follicular tumors in dogs and cats are just as rare as they are in people.